The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Newman Michael James since 2022.
This trader's CIK number is 1876315.
At the time of last reporting, Newman Michael James was the CSO and Director of Indaptus Therapeutics, Inc.. (stock ticker symbol INDP).
Also see all insider trading activities at Indaptus Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | INDP | 0 | $0 | 20,000 | $100,042 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-01-31 | INDP | Sale | 5,870 | 5.00 | 29,350 |
| 2022-02-01 | INDP | Sale | 14,130 | 5.00 | 70,692 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Newman Michael James (CSO and Director of Indaptus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.